Internal Medicine, Medical Oncology · Mishawaka, IN
NPI
1386648749
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5340 Holy Cross Pkwy
Mishawaka, IN, 46545
Phone (574) 237-1328
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.0M
156,704 services
Medicare patients, 2024
1,357
Average age 75
Drug cost, 2024
$11.7M
4,555 prescriptions
Company payments, 2025
$2,734
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bilal Ansari was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 28,320 times for 218 patients. In total Bilal Ansari billed 156,704 services in 152 codes, and Medicare paid $2.0M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-15.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 28,320 | 218 | $0.10 | $2,881 |
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 12,480 | 12 | $0.41 | $5,082 |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 10,260 | 12 | $2.29 | $24K |
| J0897 Injection, denosumab, 1 mg | Office | 5,580 | 27 | $20.18 | $113K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 3,800 | 11 | $43.58 | $166K |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 2,980 | 11 | $0.06 | $173 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,692 | 86 | $0.09 | $239 |
| 99214 Office E&M - Established | Office | 2,230 | 892 | $85.45 | $191K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,140 | 35 | $0.73 | $832 |
| J0640 Injection, leucovorin calcium, per 50 mg | Office | 918 | 13 | $3.66 | $3,360 |
| 99213 Office E&M - Established | Office | 892 | 614 | $63.57 | $57K |
| 96375 Injection Administration | Office | 576 | 89 | $10.95 | $6,310 |
| J9190 Injection, fluorouracil, 500 mg | Office | 540 | 17 | $2.35 | $1,268 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 432 | 23 | $0.07 | $32.05 |
| 96413 Chemotherapy Administration | Office | 268 | 77 | $90.13 | $24K |
By year: 2022 $4.3M for 194,990 services; 2023 $3.5M for 227,664 services; 2024 $2.0M for 156,704 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bilal Ansari prescribed most often to Medicare patients was Letrozole, with 549 prescriptions and refills. In total Bilal Ansari wrote 4,555 Medicare prescriptions that cost $11.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 549 | 1,301 | 155 | $14K |
| Xarelto Rivaroxaban | 242 | 387 | 49 | $213K |
| Pantoprazole Sodium Generic | 195 | 404 | 78 | $1,791 |
| Prednisone Generic | 147 | 182 | 72 | $481 |
| Prochlorperazine Maleate Generic | 141 | 141 | 99 | $2,255 |
| Ondansetron Odt Ondansetron | 128 | 129 | 83 | $2,394 |
| Gabapentin Generic | 127 | 176 | 33 | $1,307 |
| Eliquis Apixaban | 119 | 174 | 30 | $94K |
| Levothyroxine Sodium Generic | 113 | 227 | 40 | $662 |
| Anastrozole Generic | 112 | 302 | 38 | $1,695 |
| Acyclovir Generic | 98 | 138 | 26 | $1,167 |
| Ibrance Palbociclib | 85 | 89 | Under 11 | $1.3M |
| Hydrocortisone Generic | 84 | 127 | 30 | $1,924 |
| Warfarin Sodium Generic | 78 | 106 | Under 11 | $414 |
| Imbruvica Ibrutinib | 71 | 71 | Under 11 | $1.1M |
Brand drugs: - claims; generic drugs: 3,241 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bilal Ansari $2,734 ($2,734 in general payments such as food, travel and fees) from 19 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,079.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 16 | $1,079 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $216 |
| Abbvie Inc. ABBV | 6 | $210 |
| Janssen Biotech, Inc. JNJ | 3 | $156 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $155 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $144 |
| Stemline Therapeutics Inc. | 3 | $143 |
| Tempus AI, Inc TEM | 2 | $140 |
| Jazz Pharmaceuticals Inc. JAZZ | 1 | $121 |
| Gilead Sciences, Inc. GILD | 1 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.